MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma
- 1 December 1997
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 33 (4) , 233-239
- https://doi.org/10.1002/(sici)1097-0045(19971201)33:4<233::aid-pros2>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Major Histocompatibility Complex Class I and Class II Expression in Renal Cell Carcinoma and Modulation by Interferon GammaJournal of Urology, 1996
- Loss of HLA class I expression in prostate cancer: Implications for immunotherapyUrology, 1995
- Incidental Lymphocytic ProstatitisThe American Journal of Surgical Pathology, 1992
- Distribution of langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological gradeThe Prostate, 1991
- DIFFERENTIAL EXPRESSION OF HLA CLASS I AND II ANTIGENS IN PRIMARY AND METASTATIC MELANOMASInternational Journal of Immunogenetics, 1986
- Loss of HLA‐A,B,C and de novo expression of HLA‐D in colorectal cancerInternational Journal of Cancer, 1986
- Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferonCell, 1985
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I GeneScience, 1985
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984